PEGylated Polyester-Based Nanoncologicals

ISSN: 1873-5294 (Online)
ISSN: 1568-0266 (Print)


Volume 14, 24 Issues, 2014


Download PDF Flyer




Current Topics in Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 11th of 58 in Chemistry, Medicinal



Editor-in-Chief:
Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc
Doylestown, PA
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.453
5 - Year: 3.826

PEGylated Polyester-Based Nanoncologicals

Author(s): Claudia Conte, Ivana d’Angelo, Agnese Miro, Francesca Ungaro and Fabiana Quaglia

Affiliation: Department of Pharmacy, University of Napoli Federico II, Via D. Montesano 49, 80131 Napoli – Italy.

Abstract

Several PEGylated polyester-based nanoncologicals have been proposed in the literature, some of them nowadays being under preclinical/clinical trials or marketed. In this review, we describe the main features of PEGylated polyesters and their correspondent nanocarriers. A first part is devoted to intravenously injectable PEGylated nanocarriers, which represent the systems most investigated so far. After describing fundamental design rules dictated by the administration route, PEGylated nanocarriers currently under preclinical/clinical investigation or in the market will be described from a technological point of view and related therapeutic implications discussed. Finally, new perspective of use of PEGylated nanocarriers for oral and pulmonary delivery of anticancer drugs will be considered.




Keywords: Cancer, chemotherapeutics, drug targeting, nanoparticles, nanotechnology, polyethylenglycol, polymers.

Purchase Online Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 14
Issue Number: 9
First Page: 1097
Last Page: 1114
Page Count: 18
DOI: 10.2174/1568026614666140329224243
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science